Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordUSCIS Data Hub records 294 H-1B approvals for this employer in FY2023 — older 2023 data; no recent Department of Labor filings (Oct 2025 – Jun 2026) were found for it.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- USCIS Data Hub records 294 H-1B approvals for this employer in FY2023 — older 2023 data; no recent Department of Labor filings (Oct 2025 – Jun 2026) were found for it. Source: US Department of Labor visa filings (LCA) (US Department of Labor (OFLC), plus USCIS H-1B Employer Data Hub).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
At U.S. Bank, we’re on a journey to do our best. Helping the customers and businesses we serve to make better and smarter financial decisions and enabling the communities we support to grow and succeed. We believe it takes all of us to bring our shared ambition to life, and each person is unique in their potential. A career with U.S. Bank gives you a wide, ever-growing range of opportunities to discover what makes you thrive at every stage of your career. Try new things, learn new skills and discover what you excel at—all from Day One.
BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. Following our acquisition by U.S. Bancorp in 2026, we combine BTIG’s high-touch, client-first approach with the scale and stability of the nation’s fifth largest commercial bank. We take pride in attracting the best and brightest individuals from diverse backgrounds and mindsets, and we continue to foster a culture where entrepreneurial spirit thrives—now supported by the resources and long-term commitment of U.S. Bancorp.
Job Description
BTIG seeks an investment banking professional to join the Biopharma Investment Banking team in New York. Associates are involved in all facets of BTIG's investment banking activities, including private and public offerings, M&A transactions, and other advisory services. The ideal candidate will demonstrate potential to take on a significant role in deal execution by providing day-to-day support to senior bankers and clients while also providing professional guidance to junior team members. BTIG offers a unique environment which combines a highly entrepreneurial platform focused on growth companies with the analytical rigor and transaction experience of “bulge bracket” investment banks.
Duties & Responsibilities:
• Provide transaction support to senior bankers on a broad range of live deals and pitches, including for IPOs, Follow-Ons, PIPEs, Private Placements, and M&A transactions
• Build detailed financial models and valuation analyses (DCF, public comps, etc.)
• Prepare client presentations, offering memoranda, and other transaction materials
• Conduct due diligence and industry research on companies, pipeline assets, and therapeutic areas
• Monitor public market activity and key trends impacting the biopharma sector
• Interact directly with clients and investors during due diligence, transaction marketing, and execution processes
Requirements & Qualifications:
• Ideal candidate will have 3+ years of experience within an investment banking biopharma vertical at a bulge bracket or middle-market investment bank
• BA/BS/MS in a life sciences-related field preferred; applicants with advanced degrees (PharmD, MD, PhD) in life sciences will be prioritized
• Experience working on successful equity capital markets transactions as well as M&A and strategic advisory assignments
• Deep understanding of biopharma business models, therapeutic areas, and drug development / regulatory timelines
• Strong analytical, financial, and valuation modeling skills
• Highly motivated with the ability to manage multiple projects with competing deadlines
• Superior attention to detail and ability to thrive in a fast-paced business environment
• Demonstrated commitment to mentoring and developing junior team members
• Excellent verbal and written communication skills, with the ability to build both internal and client-facing relationships
• Advanced proficiency in Excel and PowerPoint; experience with relevant banking-related databases / applications (Bloomberg, CapIQ, Pitchbook, etc.)
• SIE, Series 63, and Series 79 licenses required
Compensation:
• Salary range is based on a variety of factors including, but not limited to
Apply on employer site ↗